AVITA Medical Inc logo

AVITA Medical Inc

$ 5.36 0 (0%) 10:08 PM EST
P/E:
At Loss
P/B:
1.45
Market Cap:
$ 134.02M
Enterprise V:
$ 50.19M
Volume:
22.84K
Avg Vol (2M):
89.72K
Also Trade In:
Volume:
22.84K
Market Cap $:
134.02M
PE Ratio:
At Loss
Avg Vol (2-Month):
89.72K
Enterprise Value $:
50.19M
PB Ratio:
1.45
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the U.S. with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 U.S. burn centres. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the U.S. region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the U.S.
Name Current Vs Industry Vs History
Cash-To-Debt 158.56
Equity-to-Asset 0.9
Debt-to-Equity 0.01
Debt-to-EBITDA -0.02
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 4.83
Distress
Grey
Safe
Beneish M-Score -0.23
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 39.57
9-Day RSI 37.25
14-Day RSI 38.5
6-1 Month Momentum % -29.93
12-1 Month Momentum % -64.95

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 11.64
Quick Ratio 11.39
Cash Ratio 10.7
Days Inventory 132.56
Days Sales Outstanding 42.67
Days Payable 188.13

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio 27

Financials (Next Earnings Date:2022-12-30 Est.)

RCEL's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:RCEL

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 29.83
EPS (TTM) ($) -1.21
Beta 0.97
Volatility % 43.94
14-Day RSI 38.5
14-Day ATR ($) 0.307498
20-Day SMA ($) 5.83475
12-1 Month Momentum % -64.95
52-Week Range ($) 4.57 - 19.86
Shares Outstanding (Mil) 25

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

AVITA Medical Inc Filings

Document Form Filing Date
No Filing Data

AVITA Medical Inc Analysis

Share your research

Headlines

See More
No news.